Marlton Partners Calls on 180 Degree Capital Corp. to Set Record Date Now and Allow Shareholders to Determine Company's Future

Stock Information for Lineage Cell Therapeutics, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lineage Cell Therapeutics, Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, TURN, STRM on Behalf of Shareholders
180 DEGREE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of 180 Degree Capital Corp. - TURN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TASK, VBTX, TURN on Behalf of Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY
180 Degree Capital Corp. Notes Filing of Definitive Materials for Proposed Business Combination with Mount Logan Capital and Will Host a Shareholder Call on Tuesday, July 15, 2025, at 1 PM ET
180 Degree Capital Corp. Notes Business and Merger-Related Updates Including:
Marlton Partners Nominates Four Highly Qualified Director Candidates For Election To 180 Degree Capital Board of Directors At Upcoming Special Meeting
180 Degree Capital Corp. Amends Election of Director Special Meeting Date Pursuant to Shareholder Demand Under New York Business Law

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.